Biogen(BIIB) - 2024 Q2 - Quarterly Results

Press Release Cambridge, Mass. – Aug. 1, 2024 Biogen reports strong second quarter 2024 results and raises full year 2024 financial guidance; Second quarter 2024 total revenue of $2.5 billion, GAAP diluted EPS of $4.00 and Non-GAAP diluted EPS of $5.28 Second quarter total revenue was flat at actual currency and up 1% at constant currency, with GAAP diluted EPS decline of 2% and Non-GAAP diluted EPS increase of 31% year-over-year • Core pharmaceutical revenue (product revenue + LEQEMBI) up 5% at actual curr ...